In ovarian cancer, TAZ regulates the level of its direct target gene angiopoietin-like 4 (ANGPTL4) to manage the activity of NADPH oxidase 2 (NOX2), finally leading to ferroptosis (Yang et al., 2020). The gene discussed is ANGPTL4; the disease is ovarian carcinoma.